New stroke drug enters early safety testing

NCT ID NCT07513233

Recruiting now Disease control Sponsor: Capital Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This early-stage study tests whether a drug called anisodine hydrobromide is safe for people having a stroke caused by a blocked large artery in the brain. About 92 adults aged 18 to 80 who are already scheduled for a clot-removal procedure will receive the drug. The main goal is to check for serious side effects like bleeding in the brain or death within 8 days of treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE

Contacts and locations

Locations

Anji County People's Hospital
RECRUITING

Huzhou, Zhejiang, 313300, China
Jiuquan City People's Hospital
RECRUITING

Jiuquan, Gansu, 735000, China
Taizhou Enze Medical Center (Group) Enze Hospital
RECRUITING

Taizhou, Zhejiang, 318053, China
The Affiliated Hospital of Xuzhou Medical University
RECRUITING

Xuzhou, Jiangsu, 221000, China
The First People's Hospital of Shangqiu
RECRUITING

Shangqiu, Henan, 476100, China
The Second People's Hospital of Yulin
RECRUITING

Yulin, Guangxi, 537000, China
Xuanwu Hospital, Capital Medical University
RECRUITING

Beijing, None Selected, 100053, China
Yueqing People's Hospital
RECRUITING

Yueqing, Zhejiang, 325600, China
Zhangpu County Hospital
RECRUITING

Zhangzhou, Fujian, 363200, China
Zibo Central Hospital
RECRUITING

Zibo, Shandong, 255036, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.